Tezepelumab for treating severe asthma (TA880)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 20 April 2023
SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (terminated appraisal) (TA834)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 12 October 2022
Dupilumab for treating severe asthma with type 2 inflammation (TA751)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 December 2021
Asthma: diagnosis, monitoring and chronic asthma management (NG80)Product type:GuidanceProgramme:NICE guidelineLast updated: 22 March 2021Published: 29 November 2017
Mepolizumab for treating severe eosinophilic asthma (TA671)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 3 February 2021
Benralizumab for treating severe eosinophilic asthma (TA565)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 3 September 2019Published: 6 March 2019
Bronchial thermoplasty for severe asthma (IPG635)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 19 December 2018
Reslizumab for treating severe eosinophilic asthma (TA479)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 October 2017
Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath (DG12)Product type:GuidanceProgramme:Diagnostics guidancePublished: 2 April 2014
Omalizumab for treating severe persistent allergic asthma (TA278)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 April 2013
Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over (TA138)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 March 2008
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years (TA131)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 November 2007
Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years) (TA38)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 March 2002
Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma (TA10)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 August 2000
Smart Peak Flow for monitoring asthma (MIB282)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 January 2022
OxyMask for delivering oxygen therapy (MIB160)Product type:AdviceProgramme:Medtech innovation briefingPublished: 27 September 2018
Smart One for measuring lung function (MIB96)Product type:AdviceProgramme:Medtech innovation briefingPublished: 9 February 2017
Smartinhaler for asthma (MIB90)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 January 2017
Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 July 2016
The Airsonett temperature-controlled laminar airflow device for persistent allergic asthma (MIB8)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 August 2014
Transforming the care of children and young people in London with asthma: Development of the London Asthma StandardsProduct type:Shared learningPublished: 4 February 2021
Childhood Asthma Management in Primary Care - Implementation of Exhaled Nitric Oxide and Spirometry Testing (CHAMPIONS study)Product type:Shared learningPublished: 31 May 2019
Modern Innovative SolutionS Improving Outcomes iN Asthma Breathlessness and COPD (MISSION ABC)Product type:Shared learningPublished: 2 February 2018
Embedding NICE guidance into GPSOC clinical systemsProduct type:Shared learningPublished: 24 January 2017
Impact of a pharmacist-led Asthma and COPD respiratory clinic in General PracticeProduct type:Shared learningPublished: 3 April 2016